Lv32
250 积分 2025-11-17 加入
Tuning Th1 Immunity through a TLR7/8 Agonist HYBRID2-Formalin-Killed Leishmania donovani Antigen Immunomodulatory System in Visceral Leishmaniasis
17小时前
已完结
Protective efficacy of heat-killed Leishmnaia donovani vaccine adjuvanted with Toll Like Receptor 7/8 agonist in BALB/c mice
17小时前
求助中
C-Reactive Protein, Interleukin-6, and Vascular Recurrence According to Stroke Subtype
2个月前
已完结
Anticoagulation strategy for patients presenting with ischemic strokes while using a direct oral anticoagulant: A systematic review and meta-analysis
2个月前
已完结
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2个月前
已完结
Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke
3个月前
已完结
Perioperative Stroke
3个月前
已完结
Macrophage immunometabolism in inflammatory bowel diseases: From pathogenesis to therapy
3个月前
已完结
Atherogenic Index of Plasma [Log(Triglycerides/HDL-Cholesterol)]: Theoretical and Practical Implications
4个月前
已完结
O37 M5049, a novel potent and selective inhibitor of toll-like receptors 7 and 8 (TLR 7/8)
6个月前
已完结
皖公网安备34019202002308
